China Grants Conditional Approval To CNBG COVID Vaccine
Executive Summary
State-owned China National Biotec Group becomes the first to get the greenlight for its inactivated virus-based vaccine to prevent COVID-19.
You may also be interested in...
Two New Vaccines Join COVID Fight As China Ships Millions Overseas
CanSino's adenovirus-based COVID-19 vaccine, along with another from state-owned Sinopharm, have been granted prompt conditional approvals in China, taking to four the number approved in the country and as Beijing ships millions of doses around the world.
Coronavirus Update: Pfizer CEO Thinks Vaccine Price Rise Likely Post-Pandemic
Companies will raise their COVID-19 vaccine prices once the pandemic is over – but key long-term data will determine which comes out on top.
Speedy Clearance Of COVID-19 Vaccines Concerns Experts In India
No one wants to take away from India’s flair and prowess in the vaccines segment, but there should be no place for doubt when it comes to rigor in scientific and regulatory processes. Experts have raised questions around the restricted emergency use clearance of two COVID-19 vaccines in India.